Large Cap Archives - Page 399 of 437

1 minute read

3M’s Lawsuit Hit-Earplug Unit Earns Faster Review For Bankruptcy Ruling

October 14, 7:29 AM

Judges from the U.S. Court of Appeals in Chicago granted 3M Co's (NYSE: MMM) bankrupt subsidiary, Aearo Technologies, a quicker-than-normal process for the review of the bankruptcy-court ruling.

MMM

2 minute read

Wait Till I Get My Money Right: Chase Bank Runs Away From Kanye West

By AJ Fabino

October 13, 5:18 PM

JP Morgan Chase & Co. (NYSE: JPM) is the latest company to distance itself from Kanye West following the rapper's anti-Semitic comments.

JPM

1 minute read

Analyst Upgrades Biogen Citing Upcoming Conference, Competitive Readouts

By Vandana Singh

October 13, 1:45 PM

Stifel upgraded Biogen Inc (NASDAQ: BIIB) from Hold to Buy, saying shares have faded since positive lecanemab data in mild Alzheimer's.

BIIB

2 minute read

As Netflix Gears Up For A New Ad-Supported Tier: Here’s What Morgan Stanley Analysts Have To Say

By AJ Fabino

October 13, 12:27 PM

Analysts at Morgan Stanley maintain an Equal Weight on streaming giant Netflix Inc. (NASDAQ: NFLX), as the potential earnings lift from introducing an ad-supported tier and paid sharing remain unknown.

NFLX

2 minute read

Billionaires George Soros, Steve Cohen Like These 2 Semiconductor Stocks – Here’s Why

By Robert Kuczmarski

October 13, 11:29 AM

Soros Fund Management and Point72 Asset Management were founded by billionaires George Soros and Steve Cohen, respectively.

ADI

1 minute read

FDA Signals Shortage For Teva Pharma’s ADHD Drug Due To Manufacturing Delay

By Vandana Singh

October 13, 6:25 AM

The FDA said that there was a shortage of Adderall after intermittent manufacturing delays at Teva Pharmaceutical Industries Ltd (NYSE: TEVA).

TEVA

1 minute read

Moderna In-Licenses Autolus’ Technology For mRNA-Based Cancer Therapeutics

By Vandana Singh

October 12, 11:30 AM

Moderna Inc (NASDAQ:MRNA) has exercised its option to license Autolus Therapeutics plc’s (NASDAQ:AUTL) proprietary binders against an undisclosed immuno-oncology target for…

AUTL

1 minute read

Yet Another Good News For Moderna, FDA Approves Its New Omicron Adapted COVID-19 Shot

By Vandana Singh

October 12, 11:21 AM

Moderna Inc (NASDAQ:MRNA) has received FDA emergency use authorization (EUA) for its BA.4/BA.5 Omicron-targeting bivalent COVID-19 booster vaccine, mRNA-1273.222, in children…

MRK

1 minute read

Moderna Shares Are Surging After Merck Exercised Personalized Cancer Vaccine Pact

By Vandana Singh

October 12, 9:26 AM

Moderna Inc (NASDAQ:MRNA) said Merck & Co Inc (NYSE:MRK) had exercised an option to jointly develop and potentially sell personalized mRNA-based cancer vaccine.…

MRK

1 minute read

US Health Official Says Updated COVID-19 Boosters Should Offer Protection Amid Tracking Emerging Variants

By Vandana Singh

October 12, 8:03 AM

The U.S. health officials are tracking several coronavirus omicron subvariants that more easily evade immunity, rendering many treatments ineffective. But the new booster shots should provide protection, said Dr. Ashish Jha, head of the White House Covid task force.

MRNA